Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1818499
Max Phase: Preclinical
Molecular Formula: C35H26BrF2N3O5
Molecular Weight: 686.51
Molecule Type: Small molecule
Associated Items:
ID: ALA1818499
Max Phase: Preclinical
Molecular Formula: C35H26BrF2N3O5
Molecular Weight: 686.51
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1ccc(C2=C(c3ccc(Br)cc3)/C(=C/c3ccc(OCC(O)(Cn4cncn4)c4ccc(F)cc4F)cc3)OC2=O)cc1
Standard InChI: InChI=1S/C35H26BrF2N3O5/c1-44-27-13-6-24(7-14-27)33-32(23-4-8-25(36)9-5-23)31(46-34(33)42)16-22-2-11-28(12-3-22)45-19-35(43,18-41-21-39-20-40-41)29-15-10-26(37)17-30(29)38/h2-17,20-21,43H,18-19H2,1H3/b31-16-
Standard InChI Key: CZURWQIOOKCOPD-ACXHZZMFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 686.51 | Molecular Weight (Monoisotopic): 685.1024 | AlogP: 6.80 | #Rotatable Bonds: 10 |
Polar Surface Area: 95.70 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 8 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.44 | CX Basic pKa: 2.00 | CX LogP: 6.84 | CX LogD: 6.84 |
Aromatic Rings: 5 | Heavy Atoms: 46 | QED Weighted: 0.16 | Np Likeness Score: -0.47 |
1. Borate HB, Sawargave SP, Chavan SP, Chandavarkar MA, Iyer R, Tawte A, Rao D, Deore JV, Kudale AS, Mahajan PS, Kangire GS.. (2011) Novel hybrids of fluconazole and furanones: design, synthesis and antifungal activity., 21 (16): [PMID:21757344] [10.1016/j.bmcl.2011.06.022] |
Source(1):